PLoS ONE 11(10):e0163907 Bjornstad P, Hughan KS, Kelsey MM, Shah A, Lynch JL, Nehus E et al (2019) 123-OR: effect of surgical vs medical therapy on diabetic kidney disease (DKD) in severely obese adolescents with type 2 diabetes (T2D)
& Fereidoon, S
Makers Novo and Lilly have pushed back, saying risks associated with GLP-1 medications are known, regulated and included in prescribing information, and have urged that all claims be handled within the existing MDL
Tirzepatide drugs (Mounjaro, Zepbound) need 72 hours
Indeed, a rise in IGF-1 levels have been observed in multiple studies of IGF-1R blockade, which is attributed to the reduction in IGF-1-mediated inhibition of GH secretion 26,40